Medaxis is pleased to announce the promotion of Dave Johnson to Chief Operating Officer. In this new role, Dave will oversee company-wide operations, ensuring strategic alignment and operational excellence as Medaxis continues to expand its global presence.

Dave Johnson brings over two decades of experience in healthcare operations, supply chain, and organizational leadership. Since joining Medaxis, he has been instrumental in streamlining internal processes, enhancing cross-functional collaboration, and driving sustainable growth across the company’s wound therapy portfolio.

“Dave’s leadership has been a cornerstone of our operational success,” said Jeffrey Castillo, Chief Executive Officer of Medaxis. “His ability to lead with clarity, drive efficiency, and inspire teams makes him the ideal choice to step into the COO role as we enter our next phase of growth.”

As COO, Dave will lead the company’s operational strategy, supply chain management, and business process optimization, with a focus on delivering high-quality, cost-effective solutions to healthcare providers and patients worldwide.

“I’m honored to take on this new role and continue contributing to Medaxis’ commitment to wound therapy solutions,” said Dave Johnson. “We have a remarkable team and a powerful vision, and I look forward to helping scale our impact in the years ahead.”